THE EFFECTIVE USE OF BEZAFIBRATE AS A SECOND LINE THERAPY FOR PRIMARY BILIARY CHOLANGITIS

被引：0
|
作者：
Howden, Adam [1 ]
Valliani, Talal [1 ]
机构：
[1] North Bristol NHS Trust Liver Unit, Bristol, Avon, England
来源：
GUT | 2021年 / 70卷
关键词：
D O I：
10.1136/gutjnl-2021-BASL.32
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P023
引用
收藏
页码：A21 / A22
页数：2
相关论文
共 50 条
  • [21] Review of Current and Upcoming Second-Line Treatments for Primary Biliary Cholangitis
    Cumpian, Nicholas A.
    Choi, Gina
    Saab, Sammy
    DIGESTIVE DISEASES AND SCIENCES, 2025, 70 (01) : 100 - 110
  • [22] PRIMARY SCLEROSING CHOLANGITIS AND PRIMARY BILIARY-CIRRHOSIS - HOW EFFECTIVE IS MEDICAL THERAPY
    FENNERTY, MB
    POSTGRADUATE MEDICINE, 1993, 94 (06) : 81 - &
  • [23] Determinants of the effectiveness of bezafibrate combined with ursodeoxycholic acid in patients with primary biliary cholangitis
    Matsumoto, Kosuke
    Hirohara, Junko
    Takeuchi, Akihito
    Miura, Ryo
    Asaoka, Yoshinari
    Nakano, Toshiaki
    Tanaka, Atsushi
    HEPATOLOGY RESEARCH, 2023, 53 (10) : 989 - 997
  • [24] Bezafibrate improves the effect of obeticholic acid on cholestasis in patients with primary biliary cholangitis
    Smets, Lena
    Liliane, Schrijvers
    Hannelie, Korf
    Schalk, Van der Merwe
    Frederik, Nevens
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E130 - E130
  • [25] Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis
    Tanaka, Atsushi
    Hirohara, Junko
    Nakano, Toshiaki
    Matsumoto, Kosuke
    Chazouilleres, Olivier
    Takikawa, Hajime
    Hansen, Bettina E.
    Carrat, Fabrice
    Corpechot, Christophe
    JOURNAL OF HEPATOLOGY, 2021, 75 (03) : 565 - 571
  • [26] Antipruritic effect of bezafibrate and serum autotaxin measures in patients with primary biliary cholangitis
    Kremer, Andreas E.
    Le Cleac'h, Aline
    Lemoinne, Sara
    Wolf, Katharina
    De Chaisemartin, Luc
    Chollet-Martin, Sylvie
    Humbert, Lydie
    Rainteau, Dominique
    Poupon, Raoul
    Rousseau, Alexandra
    Chazouilleres, Olivier
    Corpechot, Christophe
    GUT, 2019, 68 (10) : 1902 - +
  • [27] PPAR Agonist effective in primary biliary Cholangitis
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (08): : 1189 - 1190
  • [28] Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis-are we there yet?
    Rodrigues, Pedro M.
    Banales, Jesus M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (02) : 247 - 248
  • [29] Long-term bezafibrate therapy does not prevent the progression of primary biliary cholangitis in patients with advanced disease
    Reig, Anna
    Patricia Llovet, Laura
    Sese, Pilar
    Carlota Londono, Maria
    Pares, Albert
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E407 - E407
  • [30] Improving Primary Biliary Cholangitis Outcomes in the Evolving Landscape of Second-Line Therapies
    Scaravaglio, Miki
    Ronca, Vincenzo
    Carbone, Marco
    Invernizzi, Pietro
    LIVER INTERNATIONAL, 2025, 45 (03)
12345